Swartz M L
Gastroenterol Nurs. 1991 Dec;14(3):144-7.
Dipentum (olsalazine sodium), a product by Pharmacia, represents the first oral delivery of sulfa-free 5-aminosalicylic acid therapy available for remission maintenance in sulfasalazineintolerant patients with ulcerative colitis. It provides a safe and well-tolerated treatment regimen that has been shown to be as effective as sulfasalazine in maintaining remission of ulcerative colitis.
得舒特(奥沙拉秦钠)是法玛西亚公司的产品,是首个可用于不耐受柳氮磺胺吡啶的溃疡性结肠炎患者缓解期维持治疗的无磺胺基5-氨基水杨酸口服制剂。它提供了一种安全且耐受性良好的治疗方案,已证明在维持溃疡性结肠炎缓解方面与柳氮磺胺吡啶同样有效。